Comparative Relaxant Effects of Ataciguat and Zaprinast on Sheep Sphincter of Oddi

Abstract

Background: Relaxing the sphincter of Oddi (SO) is an important process during endoscopic retrograde cholangiopancreatography (ERCP) procedures. This issue suggests that the easier the sphincterotomy and cannulation, the more post-ERCP complications decrease. Aims: To compare the relaxant effects of ataciguat (a novel soluble guanylyl cyclase activator) and zaprinast (an inhibitor of phosphodiesterase 5) on sheep SO in vitro, thus testing whether they can be used during ERCP. Study Design: Animal experimentation. Methods: Sheep SO rings were placed in tissue baths and their isometric tension to ataciguat and zaprinast were tested. We also tested their isometric tension against ataciguat in the presence of 1H-(1,2,4) oxadiazole (4,3-a) quinoxalin- 1-one (ODQ) which is a soluble guanylyl cyclase inhibitor. Results: Ataciguat and zaprinast both triggered concentration addicted relaxation on sheep SO rings (p=0.0018, p=0.0025 respectively) but the relaxation of the ataciguat was significantly greater than that of zaprinast at all concentrations (p=0.0024). It was observed that decreased relaxation responses were initiated by ataciguat in the presence of ODQ (p=0.0012). Conclusion: Ataciguat and zaprinast both have relaxing effects on sphincter of Oddi, although that of zaprinast is lower. We believe that ataciguat and zaprinast can be used in ERCP procedures in order to relax the sphincter of Oddi and thus can be used locally in order to decrease complications.

Keywords

• Ataciguat, Oddi’s sphincter, zaprinast

References

1. 1. Bosch A, Peña LR. The sphincter of oddi. Dig Dis Sci 2007;52:1211-8. [Crossref]
2. 2. Woods CM, Mawe GM, Toouli J, Saccone GT. The sphincter of Oddi: understanding its control and function. Neurogastroenterol Motil 2005;1:31-40. [Crossref]
3. 3. Wells DG, Talmage EK, Mawe GM. Immunohistochemical identification of neurons in ganglia of the guinea pig sphincter of Oddi. J Comp Neurol 1995;352:106-16. [Crossref]
4. 4. Mourelle M, Guarner F, Moncada S, Malagelada JR. The arginine/nitric oxide pathway modulates sphincter of Oddi motor activity in guinea pigs and rabbits. Gastroenterology 1993;105:1299-305. [Crossref]
5. 5. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
6. 6. Sarac B, Durmus N, Bagcivan I, Altun A, Turan M, Sencan M. Investigation of relaxant effects of new agents affecting nitric oxide/cyclic guanosine monophosphate pathway on sheep oddi sphincter. Pancreas 2010;39:875-8. [Crossref]
7. 7. Denninger JW, Marletta MA. Guanylate cyclase and the NO/ cGMP signaling pathway. Biochim Biophys Acta 1999;1411:334- 50. [Crossref]
8. 8. Cosyns SM, Huyghe L, Thoonen R, Stasch JP, Brouckaert P, Lefebvre RA. Influence of cinaciguat on gastrointestinal motility in apo-sGC mice. Neurogastroenterol Motil 2014;26:1573- 85. [Crossref]

9. 9. Choi SH, Choi DH, Song KS, Shin KH, Chun BG. Zaprinast, an inhibitor of cGMP-selective phosphodiesterases, enhances the secretion of TNF-alpha and IL-1beta and the expression of iNOS and MHC class II molecules in rat microglial cells. J Neurosci Res 2002;67:411-21. [Crossref]
10. 10. Taniguchi Y, Tonai-Kachi H, Shinjo K. Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 2006;580:5003-8. [Crossref]
11. 11. Ballester C, Sarriá B, García-Granero E, Morcillo EJ, Lledó S, Cortijo J. Relaxation of the isolated human internal anal sphincter by sildenafil. Br J Surg 2007;94:894-902. [Crossref]
12. 12. Tsai BM, Wang M, Pitcher JM, Kher A, Crisostomo P, Meldrum DR. Zaprinast attenuates hypoxic pulmonary artery injury and causes less aortic relaxation than milrinone. Shock 2005;24:417- 20. [Crossref]
13. 13. Jones OM, Brading AF, McC Mortensen NJ. Phosphodiesterase inhibitors cause relaxation of the internal anal sphincter in vitro. Dis Colon Rectum 2002;45:530-6. [Crossref]
14. 14. Williams SJ, Parsons ME. Nitric oxide, an enteric nonadrenergic-noncholinergic relaxant transmitter: evidence using phosphodiesterase V and nitric oxide synthase inhibition. Br J Pharmacol 1995;116:1789-96. [Crossref]
15. 15. Huang LY, Liu YX, Wu CR. Application ofendoscopic retrograde cholangiopancreatography in biliarypancreatic diseases. Chinese Med J 2009;122:2967-72.